X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9072) 9072
Book Review (1602) 1602
Newsletter (728) 728
Publication (429) 429
Conference Proceeding (117) 117
Newspaper Article (116) 116
Book Chapter (41) 41
Magazine Article (38) 38
Trade Publication Article (6) 6
Transcript (6) 6
Dissertation (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Archival Material (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adalimumab (8429) 8429
humans (6027) 6027
index medicus (5820) 5820
infliximab (4204) 4204
female (3561) 3561
male (3327) 3327
adult (2766) 2766
middle aged (2741) 2741
tumor necrosis factor-alpha - antagonists & inhibitors (2721) 2721
etanercept (2608) 2608
rheumatology (2180) 2180
treatment outcome (2177) 2177
antibodies, monoclonal - therapeutic use (2098) 2098
rheumatoid arthritis (1768) 1768
arthritis, rheumatoid - drug therapy (1723) 1723
antirheumatic agents - therapeutic use (1719) 1719
antibodies, monoclonal, humanized (1669) 1669
aged (1357) 1357
therapy (1333) 1333
psoriasis (1287) 1287
antibodies, monoclonal, humanized - therapeutic use (1268) 1268
dermatology (1246) 1246
gastroenterology & hepatology (1239) 1239
care and treatment (1172) 1172
rheumatoid-arthritis (1132) 1132
efficacy (1043) 1043
drug therapy (1016) 1016
arthritis (1008) 1008
adalimumab - therapeutic use (1005) 1005
anti-inflammatory agents - therapeutic use (1001) 1001
double-blind (987) 987
crohn's disease (985) 985
antibodies, monoclonal - adverse effects (959) 959
tumor necrosis factor (940) 940
crohn disease - drug therapy (935) 935
severity of illness index (933) 933
methotrexate (921) 921
immunoglobulin g - therapeutic use (896) 896
receptors, tumor necrosis factor - therapeutic use (892) 892
psoriasis - drug therapy (814) 814
safety (808) 808
research (807) 807
antirheumatic agents - adverse effects (785) 785
young adult (773) 773
retrospective studies (762) 762
inflammatory-bowel-disease (749) 749
crohns-disease (747) 747
pharmacology & pharmacy (723) 723
adolescent (655) 655
abridged index medicus (654) 654
inflammatory bowel disease (654) 654
medicine & public health (642) 642
drug therapy, combination (639) 639
risk factors (632) 632
rheumatoid factor (622) 622
analysis (616) 616
ulcerative colitis (608) 608
medical research (600) 600
immunotherapy (583) 583
antibodies, monoclonal, humanized - adverse effects (565) 565
medicine, experimental (563) 563
monoclonal antibodies (553) 553
trial (547) 547
tumor necrosis factor-tnf (547) 547
methotrexate - therapeutic use (543) 543
disease (512) 512
dosage and administration (507) 507
immunosuppressive agents - therapeutic use (500) 500
infliximab - therapeutic use (500) 500
patients (481) 481
follow-up studies (478) 478
time factors (471) 471
remission induction (466) 466
prospective studies (461) 461
immunology (451) 451
antibodies, monoclonal - administration & dosage (446) 446
placebo-controlled trial (445) 445
certolizumab pegol (433) 433
clinical trials (428) 428
monoclonal-antibody (428) 428
remission (423) 423
medicine, general & internal (421) 421
anti-inflammatory agents - adverse effects (412) 412
arthritis, psoriatic - drug therapy (407) 407
biological products - therapeutic use (406) 406
immunoglobulin g - adverse effects (402) 402
psoriatic arthritis (391) 391
tumor necrosis factor-alpha - immunology (390) 390
ankylosing spondylitis (388) 388
antirheumatic agents - administration & dosage (388) 388
health aspects (386) 386
anti-tnf (382) 382
complications and side effects (377) 377
adalimumab - adverse effects (373) 373
quality of life (372) 372
inflammation (371) 371
necrosis-factor-alpha (368) 368
biologics (361) 361
antibodies (360) 360
child (352) 352
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9109) 9109
Spanish (224) 224
German (162) 162
French (152) 152
Korean (79) 79
Japanese (71) 71
Russian (44) 44
Polish (37) 37
Italian (36) 36
Hungarian (27) 27
Portuguese (27) 27
Danish (19) 19
Czech (17) 17
Turkish (15) 15
Croatian (12) 12
Dutch (8) 8
Chinese (5) 5
Slovak (4) 4
Swedish (3) 3
Finnish (2) 2
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 08/2019, Volume 17, Issue 8, pp. 837 - 839
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 08/2019, Volume 17, Issue 8, pp. 837 - 838
Journal Article
Journal Article
Journal Article
Journal Article
Rheumatology, ISSN 1462-0324, 02/2019, Volume 58, Issue Supplement_1, pp. i1 - i3
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 5, pp. 422 - 434
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 08/2019, Volume 33, Issue 8, pp. e298 - e300
Linked article: M. Kovacs et al. J Eur Acad Dermatol Venereol 2019; 33 : e300. https://doi.org/10.1111/jdv.15573 
ADALIMUMAB | DERMATOLOGY | Index Medicus
Journal Article
ANNALS OF THE RHEUMATIC DISEASES, ISSN 0003-4967, 06/2019, Volume 78, pp. 358 - 358
Conference Proceeding
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 02/2019, Volume 33, Issue 2, pp. e84 - e87
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 67, Issue 1, pp. 53 - 53
Objective The efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article